Key Takeaways Expansion of product offerings and strategic acquisitions are enhancing innovation, reducing operational costs, and solidifying leadership in advanced genomics tools. Growth in global partnerships and improved international presence are increasing market opportunities and supporting resilient, long-term revenue streams.Read more
Key Takeaways Accelerating adoption of innovative products and new data-driven applications is driving faster-than-expected revenue growth and expanding high-margin software and consumables streams. Expansion in biopharma, global research, and new regulatory-backed markets are enabling rapid, diversified growth and improved long-term earnings stability.Read more
Key Takeaways Uncertain government and academic funding, plus shifting policy priorities, threaten core revenue growth and long-term market potential. Competitive pressure, high costs, and regulatory risks may erode margins and market share, limiting profitability and earnings recovery.Read more
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
